To evaluate the role of FDG PET/CT in the preoperative N-staging of high-risk clinical stage I endometrial cancer. The correlation between the metabolic characteristics of endometrial tumor uptake as predictors of a) lymph-node (LN) metastases and b) recurrence, was also evaluated.
Crivellaro, C., Signorelli, M., Guerra, L., De Ponti, E., Pirovano, C., Fruscio, R., et al. (2013). Tailoring systematic lymphadenectomy in high-risk clinical early stage endometrial cancer: the role of 18F-FDG PET/CT. GYNECOLOGIC ONCOLOGY, 130(2), 306-311 [10.1016/j.ygyno.2013.05.011].
Tailoring systematic lymphadenectomy in high-risk clinical early stage endometrial cancer: the role of 18F-FDG PET/CT
CRIVELLARO, CINZIA;SIGNORELLI, MAURO;Guerra, L;De Ponti, E;FRUSCIO, ROBERT;MONTANELLI, LUCA;BUDA, ALESSANDRO ANTONIO;MESSA, MARIA CRISTINA
2013
Abstract
To evaluate the role of FDG PET/CT in the preoperative N-staging of high-risk clinical stage I endometrial cancer. The correlation between the metabolic characteristics of endometrial tumor uptake as predictors of a) lymph-node (LN) metastases and b) recurrence, was also evaluated.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
